|
1
|
Rini BI, Rathmell WK and Godley P: Renal
cell carcinoma. Curr Opin Oncol. 20:300–306. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stephenson AJ, Chetner MP, Rourke K,
Gleave ME, Signaevsky M, Palmer B, Kuan J, Brock GB and Tanguay S:
Guidelines for the surveillance of localized renal cell carcinoma
based on the patterns of relapse after nephrectomy. J Urol.
172:58–62. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cohen HT and McGovern FJ: Renal-cell
carcinoma. New Engl J Med. 353:2477–2490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lambea J, Anido U, Etxániz O, Flores L,
Montesa Á, Sepúlveda JM and Esteban E: The Wide Experience of the
Sequential Therapy for Patients with Metastatic Renal Cell
Carcinoma. Curr Oncol Rep. 18:662016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calvo E, Grünwald V and Bellmunt J:
Controversies in renal cell carcinoma: Treatment choice after
progression on vascular endothelial growth factor-targeted therapy.
Eur J Cancer. 50:1321–1329. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Miyata Y, Kanda S, Sakai H and Greer PA:
Feline sarcoma-related protein expression correlates with malignant
aggressiveness and poor prognosis in renal cell carcinoma. Cancer
Sci. 104:681–686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ben-Dor I, Bern O, Tennenbaum T and Nir U:
Cell cycle-dependent nuclear accumulation of the p94fer tyrosine
kinase is regulated by its NH2 terminus and is affected by kinase
domain integrity an. Cell Growth Differ. 10:113–129.
1999.PubMed/NCBI
|
|
8
|
Greer P: Closing in on the biological
functions of FPS/FES and FER. Nat Rev Mol Cell Biol. 3:278–289.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sangrar W, Gao Y, Scott M, Truesdell P and
Greer PA: Fer-mediated cortactin phosphorylation is associated with
efficient fibroblast migration and is dependent on reactive oxygen
species generation during integrin-mediated cell adhesion. Mol Cell
Biol. 27:6140–6152. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Craig AW: FES/FER kinase signaling in
hematopoietic cells and leukemias. Front Biosci (Landmark Ed).
17:861–875. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim L and Wong TW: Growth factor-dependent
phosphorylation of the actin-binding protein cortactin is mediated
by the cytoplasmic tyrosine kinase FER. J Biol Chem.
273:23542–23548. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hayun R, Shpungin S, Malovani H, Albeck M,
Okun E, Nir U and Sredni B: Novel involvement of the
immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase
Fer. Ann N Y Acad Sci. 1095:240–250. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoneyama T, Angata K, Bao X, Courtneidge
S, Chanda SK and Fukuda M: Fer kinase regulates cell migration
though α-dystroglycan glycosylation. Mol Biol Cell. 23:771–780.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allard P, Zoubeidi A, Nguyen LT, Tessier
S, Tanguay S, Chevrette M, Aprikian A and Chevalier S: Links
between Fer tyrosine kinase expression levels and prostate cell
proliferation. Mol Cell Endocrinol. 159:63–77. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li H, Ren Z, Kang X, Zhang L, Li X, Wang
Y, Xue T, Shen Y and Liu Y: Identification of
tyrosine-phosphorylated proteins associated with metastasis and
functional analysis of FER in human hepatocellular carcinoma cells.
BMC Cancer. 9:3662009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ivanova IA, Vermeulen JF, Ercan C,
Houthuijzen JM, Saig FA, Vlug EJ, van der Wall E, van Diest PJ,
Vooijs M and Derksen PW: FER kinase promotes breast cancer
metastasis by regulating α6- and β1-integrin-dependent cell
adhesion and anoikis resitance. Oncogene. 32:5582–5592. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vitale MG and Cartenì G: Clinical
management of metastatic kidney cancer: The role of new molecular
drugs. Future Oncol. 12:83–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hashimoto O, Yoshida M, Koma Y, Yanai T,
Hasegawa D, Kosaka Y, Nishimura N and Yokozaki H: Collaboration of
cancer-associated fibroblasts and tumour-associated macrophages for
neuroblastoma development. J Pathol. 240:211–223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watanabe S, Miyata Y, Matsuo T, Mochizuki
Y, Nishikido M, Hayashi T and Sakai H: High density of
tryptase-positive mast cells in patients with renal cell carcinoma
on hemodialysis: Correlation with expression of stem cell factor
and protease activated receptor-2. Hum Pathol. 43:888–897. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Matsuo T, Miyata Y, Watanabe S, Ohba K,
Hayashi T, Kanda S and Sakai H: Pathologic significance and
prognostic value of phosphorylated cortactin expression in patients
with sarcomatoid renal cell carcinoma. Urology. 476:e9–15.
2011.
|
|
21
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. 6th.
Springer-Verlag; New York, NY: pp. 157–164. 2002
|
|
22
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyata Y, Watanabe S, Kanetake H and Sakai
H: Thrombospondin-1-derived 4N1K peptide expression is negatively
associated with malignant aggressiveness and prognosis in
urothelial carcinoma of the upper urinary tract. BMC Cancer.
12:3722012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watanabe S, Miyata Y, Kanda S, Iwata T,
Hayashi T, Kanetake H and Sakai H: Expression of X-linked inhibitor
of apoptosis protein in human prostate cancer specimens with and
without neo-adjuvant hormonal therapy. J Cancer Res Clin Oncol.
136:787–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Wever O, Demetter P, Mareel M and
Bracke M: Stromal myofibroblasts are drivers of invasive cancer
growth. Int J Cancer. 123:2229–2238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ahn J, Truesdell P, Meens J, Kadish C,
Yang X, Boag AH and Craig AW: Fer protein-tyrosine kinase promotes
lung adenocarcinoma cell invasion and tumor metastasis. Mol Cancer
Res. 11:952–963. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim L and Wong TW: The cytoplasmic
tyrosine kinase FER is associated with the catenin-like substrate
pp120 and is activated by growth factors. Mol Cell Biol.
15:4553–4561. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rosato R, Veltmaat JM, Groffen J and
Heisterkamp N: Involvement of the tyrosine kinease fer in cell
adhesion. Mol Cell Biol. 18:5762–5770. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fullár A, Dudás J, Oláh L, Hollósi P, Papp
Z, Sobel G, Karászi K, Paku S, Baghy K and Kovalszky I: Remodeling
of extracellular matrix by normal and tumor-associated fibroblasts
promotes cervical cancer progression. BMC Cancer. 15:2562015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Trylcova J, Busek P, Smetana K Jr,
Balaziova E, Dvorankova B, Mifkova A and Sedo A: Effect of
cancer-associated fibroblasts on the migration of glioma cells in
vitro. Tumour Biol. 36:5873–5879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohba K, Miyata Y, Kanda S, Koga S, Hayashi
T and Kanetake H: Expression of urokinase-type plasminogen
activator, urokinase-type plasminogen activator receptor and
plasminogen activator inhibitors in patients with renal cell
carcinoma: Correlation with tumor associated macrophage and
prognosis. J Urol. 174:461–465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tchou J, Zhang PJ, Bi Y, Satija C,
Marjumdar R, Stephen TL, Lo A, Chen H, Mies C, June CH, et al:
Fibroblast activation protein expression by stromal cells and
tumor-associated macrophages in human breast cancer. Hum Pathol.
44:2549–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McCafferty DM, Craig AW, Senis YA and
Greer PA: Absence of Fer protein-tyrosine kinase exacerbates
leukocyte recruitment in response to endotoxin. J Immunol.
168:4930–4935. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khajah M, Andronegui G, Chan R, Craig AW,
Greer PA and McCafferty DM: Fer kinase limits neutrophil chemotaxis
toward end target chemoattractants. J immunol. 190:2208–2216. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Salem Y, Shpungin S, Pasder O, Pomp O,
Taler M, Malovani H and Nir U: Fer kinase sustains the activation
level of ERK1/2 and increases the production of VEGF in hypoxic
cells. Cell Signal. 17:341–353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Donskov Fa and von der Maase H: Impact of
immune parameters on long-term survival in metastatic renal cell
carcinoma. J Clin Oncol. 24:1997–2005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vandercappellen J, Van Dammet J and Struyf
S: The role of CXC chemokines and their receptors in cancer. Cancer
Lett. 267:226–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mueller SK, Altvater B, Chen C,
Kailayangiri S, Ahlmann M, Dirksen U, Juergens H and Rossig C:
Zoledronic acid negatively affects the expansion of in vitro
activated human NK cells and their cytolytic interactions with
Ewing sarcoma cells. Oncol Rep. 29:2348–2354. 2013.PubMed/NCBI
|
|
40
|
Sangrer W, Shi C, Mullins G, LeBrun D,
Ingalls B and Greer PA: Amplified Ras-MARK signal states correlate
with accelerated EGFR internalization, cytostasis and delayed HER2
tumor onset in Fer-deficient model systems. Oncogene. 34:4109–4117.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hellwig S, Miduturu CV, Kanda S, Zhang J,
Filippakopoulos P, Salah E, Deng X, Choi HG, Zhou W, Hur W, et al:
Small-molecule inhibitors of the c-Fes protein-kinase kinase. Chem
Biol. 19:529–540. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kanda S and Miyata Y: The c-Fes protein
tyrosine kinase as a potential anti-angiogenic target in cancer.
Front Biosci (Landmark Ed). 16:1024–1035. 2011. View Article : Google Scholar : PubMed/NCBI
|
